ID   IRAK3_HUMAN             Reviewed;         535 AA.
AC   Q9Y616-2;
DT   09-NOV-2004, integrated into UniProtKB/Swiss-Prot.
DT   08-FEB-2011, sequence version 2.
DT   12-OCT-2022, entry version 185.
DE   RecName: Full=Isoform 2 of Interleukin-1 receptor-associated kinase 3;
DE            Short=IRAK-3;
DE   AltName: Full=IL-1 receptor-associated kinase M;
DE            Short=IRAK-M;
DE   AltName: Full=Inactive IL-1 receptor-associated kinase 3 {ECO:0000305};
GN   Name=IRAK3 {ECO:0000312|EMBL:AAH57800.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAD40879.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY, AND
RP   VARIANT VAL-147.
RC   TISSUE=Peripheral blood lymphocyte;
RX   PubMed=10383454; DOI=10.1074/jbc.274.27.19403;
RA   Wesche H., Gao X., Li X., Kirschning C.J., Stark G.R., Cao Z.;
RT   "IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated
RT   kinase (IRAK) family.";
RL   J. Biol. Chem. 274:19403-19410(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT VAL-147.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4] {ECO:0000312|EMBL:AAH57800.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT VAL-147.
RC   TISSUE=Placenta {ECO:0000312|EMBL:AAH57800.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INVOLVEMENT IN ASRT5, AND VARIANTS LEU-22; ALA-111; MET-134; VAL-400 AND
RP   GLN-429.
RX   PubMed=17503328; DOI=10.1086/518259;
RA   Balaci L., Spada M.C., Olla N., Sole G., Loddo L., Anedda F., Naitza S.,
RA   Zuncheddu M.A., Maschio A., Altea D., Uda M., Pilia S., Sanna S.,
RA   Masala M., Crisponi L., Fattori M., Devoto M., Doratiotto S., Rassu S.,
RA   Mereu S., Giua E., Cadeddu N.G., Atzeni R., Pelosi U., Corrias A.,
RA   Perra R., Torrazza P.L., Pirina P., Ginesu F., Marcias S., Schintu M.G.,
RA   Del Giacco G.S., Manconi P.E., Malerba G., Bisognin A., Trabetti E.,
RA   Boner A., Pescollderungg L., Pignatti P.F., Schlessinger D., Cao A.,
RA   Pilia G.;
RT   "IRAK-M is involved in the pathogenesis of early-onset persistent asthma.";
RL   Am. J. Hum. Genet. 80:1103-1114(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-467, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [7] {ECO:0007744|PDB:5UKE}
RP   STRUCTURE BY NMR OF 1-119 OF MUTANTS ASP-56 AND GLU-61, FUNCTION,
RP   INTERACTION WITH PIN1, SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   PHOSPHORYLATION AT SER-110, ISOMERIZATION AT 110-SER-PRO-111, MUTAGENESIS
RP   OF SER-110 AND SER-467, AND VARIANT ALA-111.
RX   PubMed=29686383; DOI=10.1038/s41467-018-03886-6;
RA   Nechama M., Kwon J., Wei S., Kyi A.T., Welner R.S., Ben-Dov I.Z.,
RA   Arredouani M.S., Asara J.M., Chen C.H., Tsai C.Y., Nelson K.F.,
RA   Kobayashi K.S., Israel E., Zhou X.Z., Nicholson L.K., Lu K.P.;
RT   "The IL-33-PIN1-IRAK-M axis is critical for type 2 immunity in IL-33-
RT   induced allergic airway inflammation.";
RL   Nat. Commun. 9:1603-1603(2018).
RN   [8] {ECO:0007744|PDB:6ZIW}
RP   X-RAY CRYSTALLOGRAPHY (2.18 ANGSTROMS) OF 141-455 IN COMPLEX WITH ATP
RP   ANALOG.
RA   Mathea S., Chatterjee D., Preuss F., Kraemer A., Knapp S.;
RT   "The IRAK3 Pseudokinase Domain Bound To ATPgammaS.";
RL   Submitted (JUN-2020) to the PDB data bank.
RN   [9] {ECO:0007744|PDB:6RUU}
RP   X-RAY CRYSTALLOGRAPHY (2.95 ANGSTROMS) OF 145-454, SUBUNIT, INTERACTION
RP   WITH IRAK4, ATP-BINDING, DISULFIDE BONDS, AND MUTAGENESIS OF LEU-210 AND
RP   GLU-214.
RX   PubMed=33238146; DOI=10.1016/j.str.2020.11.004;
RA   Lange S.M., Nelen M.I., Cohen P., Kulathu Y.;
RT   "Dimeric Structure of the Pseudokinase IRAK3 Suggests an Allosteric
RT   Mechanism for Negative Regulation.";
RL   Structure 29:238-251.e4(2021).
RN   [10]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-57; SER-84; VAL-147; VAL-171; LEU-288;
RP   GLN-384; THR-391 AND ASN-482.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y616-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y616-2; Sequence=VSP_041020;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   CCDS; CCDS44937.1; -.
DR   RefSeq; NP_001135995.1; NM_001142523.1.
DR   ProteomicsDB; 86579; -.
DR   Ensembl; ENST00000457197.2; ENSP00000409852.2; ENSG00000090376.11.
DR   Proteomes; UP000005640; Chromosome 12.
PE   1: Evidence at protein level;
SQ   SEQUENCE   535 AA;  60608 MW;  54DEDA8A162DD662 CRC64;
     MAGNCGARGA LSAHTLLFDL PPALLGELCA VLDSCDGALG WRGLGAVLSP SEKSYQEGGF
     PNILFKETAN VTVDNVLIPE HNEKGILLKS SISFQNIIEG TRNFHKDFLI GEGEIFEVYR
     VEIQNLTYAV KLFKQEKKMQ CKKHWKRFLS ELEVLLLFHH PNILELAAYF TETEKFCLIY
     PYMRNGTLFD RLQCVGDTAP LPWHIRIGIL IGISKAIHYL HNVQPCSVIC GSISSANILL
     DDQFQPKLTD FAMAHFRSHL EHQSCTINMT SSSSKHLWYM PEEYIRQGKL SIKTDVYSFG
     IVIMEVLTGC RVVLDDPKHI QLRDLLRELM EKRGLDSCLS FLDKKVPPCP RNFSAKLFCL
     AGRCAATRAK LRPSMDEVLN TLESTQASLY FAEDPPTSLK SFRCPSPLFL ENVPSIPVED
     DESQNNNLLP SDEGLRIDRM TQKTPFECSQ SEVMFLSLDK KPESKRNEEA CNMPSSSCEE
     SWFPKYIVPS QDLRPYKVNI DPSSEAPGHS CRSRPVESSC SSKFSWDEYE QYKKE
//
